Training our immune systems: Why we should insist on a high-quality COVID-19 vaccine

A worker inspects vials of a SARS CoV-2 vaccine for COVID-19 produced by SinoVac at its factory in Beijing on Sept. 24, 2020. (AP Photo/Ng Han Guan) Byram W. Bridle, University of Guelph; Samira Mubareka, University of Toronto, and Shayan Sharif, University of Guelph Athletes understand that there are two very different approaches that can … Continue reading Training our immune systems: Why we should insist on a high-quality COVID-19 vaccine